Adult B Cell ALL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON) (NCT04035434) | CRISPR Therapeutics AG | 2019-07-22 |
Track Adult B Cell ALL automatically
Every clearance here is in the API, with alerts when new ones post.